Renate van Uden 

Researcher & Hospital Pharmacist, Spaarne Gasthuis

Renate obtained her Master’s degree in Pharmacy at Utrecht University. She started her training as a hospital pharmacist at the Spaarne Gasthuis. Part of her training was completed at the Academic Medical Center (AMC) in Amsterdam. During her specialization, she developed a strong interest in antithrombotic therapy.  She saw in this field a valuable opportunity for hospital pharmacists to demonstrate their clinical relevance.

Her registration research focused on the frequency of unintentional guideline deviations in hospitalized patients who used combined antithrombotic therapy and whether pharmacist-led interventions were beneficial in reducing this frequency. This research laid the groundwork for her PhD project, which she began upon completing her hospital pharmacy training in 2019.

Since 2022, she has combined clinical work and research: she works parttime as a researcher and parttime as a hospital pharmacist. Her responsibilities include oncology, nuclear medicine and antithrombotic therapy. She is also a member of the antithrombotic Committee at the Spaarne Gasthuis and the Specialized Interest Group for Hematology of the Dutch Association of Hospital Pharmacists (NVZA).

Presentation: The effect of a pharmaceutical discharge letter on guideline adherence in patients with combined antithrombotic therapy

Guidelines recommend a limited duration for combined antithrombotic therapy, often initiated during hospitalization with an intended stop date after discharge. Clear communication of this stop date to community pharmacies is essential to prevent unintentional continuation. This pre-post intervention study evaluated the impact of a pharmaceutical discharge letter on the continuation of therapy after the intended stop date. In the pre-intervention group (May 2018–Aug 2019), usual care was provided. In the post-intervention group (Aug 2020–May 2021), a discharge letter including therapy details and stop date was sent to the community pharmacy. The proportion of antithrombotics dispensed after the stop date significantly decreased. In the pre-intervention group, 22.1% (57/258) of all dispensed antithrombotic drugs were dispensed after the intended stop date versus 9.3% (35/378) in the post-intervention group (ORadj 0.31, 95% CI 0.19–0.51).A pharmaceutical discharge letter reduces unintentional continuation of combined antithrombotic therapy.

Contact           

Connect                   

Veerstraat 37
1211 HJ Hilversum

Chamber of Commerce: 32110979
VAT no: NL8184.34.491.B01
         
 
 

                                    


Register now

© Copyright 2023 by Hyphen Projects | All rights reserved